Active, Not Recruiting
A Study to Evaluate the Efficacy and Safety of CAEL-101 in Patients With Mayo Stage IIIa AL Amyloidosis (CARES)
NCT04512235
- Conditions
- AL Amyloidosis, Amyloidosis, Blood Protein Disorders, +13 more
- Locations
-
- Research Site Scottsdale, Arizona, United States
- Research Site Duarte, California, United States
- Research Site Palo Alto, California, United States
- Research Site San Francisco, California, United States